69 related articles for article (PubMed ID: 16155798)
1. Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families.
Eerola H; Heikkilä P; Tamminen A; Aittomäki K; Blomqvist C; Nevanlinna H
Breast Cancer Res; 2005; 7(4):R465-9. PubMed ID: 15987451
[TBL] [Abstract][Full Text] [Related]
2. X chromosome inactivation pattern in BRCA gene mutation carriers.
Manoukian S; Verderio P; Tabano S; Colapietro P; Pizzamiglio S; Grati FR; Calvello M; Peissel B; Burn J; Pensotti V; Allemani C; Sirchia SM; Radice P; Miozzo M
Eur J Cancer; 2013 Mar; 49(5):1136-41. PubMed ID: 23146957
[TBL] [Abstract][Full Text] [Related]
3. Safety of Pregnancy After Breast Cancer in BRCA Mutation Carriers.
Newman LA; Shippee Rockefeller E; Yip CH
JAMA Surg; 2024 May; 159(5):482-483. PubMed ID: 38536201
[No Abstract] [Full Text] [Related]
4. Breast Cancer and Pregnancy in Young BRCA Carriers.
Narod SA
JAMA; 2024 Apr; 331(14):1233-1234. PubMed ID: 38592393
[No Abstract] [Full Text] [Related]
5. Experience of BRCA1/2 mutation-negative young women from families with hereditary breast and ovarian cancer: a qualitative study.
Macrae L; de Souza AN; Loiselle CG; Wong N
Hered Cancer Clin Pract; 2013 Oct; 11(1):14. PubMed ID: 24131499
[TBL] [Abstract][Full Text] [Related]
6. A Frailty-Model-Based Method for Estimating Age-Dependent Penetrance from Family Data.
Choi YH
J Biom Biostat; 2012 Feb; Suppl 4(1):. PubMed ID: 24294538
[TBL] [Abstract][Full Text] [Related]
7. Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado.
Mullineaux LG; Castellano TM; Shaw J; Axell L; Wood ME; Diab S; Klein C; Sitarik M; Deffenbaugh AM; Graw SL
Cancer; 2003 Aug; 98(3):597-602. PubMed ID: 12879478
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 and sex ratio.
Struewing JP; Hartge P; Wacholder S; Tucker MA; Greene MH
Eur J Hum Genet; 2004 Aug; 12(8):663-7. PubMed ID: 15114373
[TBL] [Abstract][Full Text] [Related]
9. Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.
Schorge JO; Mahoney NM; Miller DS; Coleman RL; Muller CY; Euhus DM; Tomlinson GE
Gynecol Oncol; 2001 Nov; 83(2):383-7. PubMed ID: 11606101
[TBL] [Abstract][Full Text] [Related]
10. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
11. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Pal T; Permuth-Wey J; Betts JA; Krischer JP; Fiorica J; Arango H; LaPolla J; Hoffman M; Martino MA; Wakeley K; Wilbanks G; Nicosia S; Cantor A; Sutphen R
Cancer; 2005 Dec; 104(12):2807-16. PubMed ID: 16284991
[TBL] [Abstract][Full Text] [Related]
13. Sex ratio distortion in offspring of families with BRCA1 or BRCA2 mutant alleles: an ascertainment bias phenomenon?
Balmaña J; Díez O; Campos B; Majewski M; Sanz J; Alonso C; Baiget M; Garber JE
Breast Cancer Res Treat; 2005 Aug; 92(3):273-7. PubMed ID: 16155798
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
